trending Market Intelligence /marketintelligence/en/news-insights/trending/kQqEqrCdyY3vesiiT0vo1Q2 content esgSubNav
In This List

Cerecor closes $10M offering to fund drug pipeline

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Cerecor closes $10M offering to fund drug pipeline

Cerecor Inc. said it closed a previously announced underwritten offering for gross proceeds of about $10 million.

The Rockville, Md.-based biopharmaceutical company offered 1,818,182 common shares for $5.50 per share.

Cerecor said H.C. Wainwright & Co. acted as the sole book-running manager for the offering.

Cerecor intends to use the net proceeds from the offering to fund the development of its neurology and pediatric rare disease pipeline as well as for general corporate purposes and working capital.